Anti-asthmatic potential of chrysin on ovalbumin-induced bronchoalveolar hyperresponsiveness in rats
Authors:
- 19 April 2011
- journal article
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 49 (5) , 508-515
Abstract
Context: Chrysin, a flavonoid obtained from various natural sources, has been reported to act as an anti-inflammatory and antioxidant agent. However, its anti-allergic action is not fully understood. Objective: In this study, we investigated the in vivo anti-asthmatic activity of chrysin. Materials and methods: The effects of chrysin were evaluated using ovalbumin (OVA) (two subcutaneous 1 mL injections of 20 μg) to induce bronchoalveolar hyperresponsiveness in rats. Chrysin, when administered at 3, 10, and 30 mg/kg, p.o., respectively, before OVA challenge, reduced inflammatory cell (total and differential cell count) infiltration into the lungs measured from bronchoalveolar lavage fluid as supported by lung histology. Results: The total lung injury score was reduced in a dose-dependent manner, evaluated in six different categories (infiltration of leucocytes, type of inflammatory exudates, status of bronchi, perivascular status of lung blood vessels, integrity of alveoli and activation of alveolar macrophages). Various cellular injury parameters such as alkaline phosphatase, lactate dehydrogenase, and total protein were estimated and found to be reduced by chrysin pretreatment. Further, chrysin was found to reduce nitrite concentration (NO) and lipid peroxidation, suggesting its antioxidant activity. Discussion and conclusion: Chrysin showed anti-asthmatic potential, probably due to the alteration of Th1/Th2 polarization via the suppression of inducible nitric oxide synthase, nuclear factor-κB, and activation protein.Keywords
This publication has 38 references indexed in Scilit:
- Apigenin protects ovalbumin-induced asthma through the regulation of GATA-3 geneInternational Immunopharmacology, 2009
- Luteolin suppresses inflammation-associated gene expression by blocking NF-κB and AP-1 activation pathway in mouse alveolar macrophagesLife Sciences, 2007
- Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway ratsEuropean Journal of Pharmacology, 2007
- Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: Analysis of the structure–activity relationshipBiochemical Pharmacology, 2006
- Targeting memory Th2 cells for the treatment of allergic asthmaPharmacology & Therapeutics, 2006
- Modulation of the activity of pro-inflammatory enzymes, COX-2 and iNOS, by chrysin derivativesPharmacological Research, 2004
- Luteolin alleviates bronchoconstriction and airway hyperreactivity in ovalbumin sensitized miceInflammation Research, 2003
- Review of the biological properties and toxicity of bee propolis (propolis)Food and Chemical Toxicology, 1998
- Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammationEuropean Respiratory Journal, 1996
- A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materialsFree Radical Biology and Medicine, 1993